Skip to content

Visual Function After Implantation of AcrySof® Toric Lens

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01074606
Enrollment
56
Registered
2010-02-24
Start date
2010-01-31
Completion date
Unknown
Last updated
2012-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Cataract

Brief summary

The objective of this study is to evaluate the postoperative visual function of Taiwanese patients following bilateral or unilateral AcrySof Toric Intraocular Lens (IOL) implantation.

Interventions

DEVICEAcrySof Toric Intraocular Lens

Implantation of the AcrySof Toric Intraocular Lens (IOL)

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Prospective subjects should be adults and may be of any race and gender, and diagnosed with cataracts. * Subject must require extraction of cataracts followed by implantation of a posterior chamber intraocular lens. * All subjects must have between 0.75 - 2.0 Diopter (D) of astigmatism preoperatively as measured by keratometry readings. * For any second eye surgery in bilateral AcrySof Toric patients, it should be performed at least one week following the first eye implant but no longer than one month after the first implant.

Exclusion criteria

* Subjects with pre-existing conditions that could skew the results should be excluded from the Study. * AcrySof® Toric product inserts under Precautions for subject groups that should be excluded from this Study.

Design outcomes

Primary

MeasureTime frame
Postoperative Refractive CylinderPre-Operative Day, 1 Month Postoperative, 3 Month Postoperative

Secondary

MeasureTime frame
Best corrected distance visual acuity (BDCVA)Pre-operative, 1 month postoperative, 3 months postoperative
Uncorrected distance visual acuity (UCDVA)Pre-Operative Day, 1 Month Postoperative, 3 Month Postoperative

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026